Notch1 is a potential therapeutic target for the treatment of human hepatitis B virus X protein-associated hepatocellular carcinoma

Sun,Qian; Wang,Ronghua; Wang,Yan; Luo,Jing; Wang,Peng; Cheng,Bin

doi:10.3892/or.2013.2917

Notch1 is a potential therapeutic target for the treatment of human hepatitis B virus X protein-associated hepatocellular carcinoma

Authors:
- Qian Sun
- Ronghua Wang
- Yan Wang
- Jing Luo
- Peng Wang
- Bin Cheng
View Affiliations

Affiliations: Department of Gastroenterology and Hepatology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, P.R. China
Published online on: December 12, 2013 https://doi.org/10.3892/or.2013.2917
Pages: 933-939

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hepatocellular carcinoma (HCC) is a highly lethal cancer with increasing worldwide incidence, and there are few therapeutics options available for patients with HCC. Thus, novel therapeutic targets for this disease are desperately needed. Chronic infection with hepatitis B virus (HBV) is the major risk factor for the development of HCC, while hepatitis B virus X protein (HBx) is essential for HBV-associated HCC. Based on our previous studies showing that HBx promoted hepatocarcinogenesis of the human non-tumor hepatic cell line L02 and activated Notch1 signaling, Notch1 short hairpin RNA (shRNA) was utilized to inhibit Notch1 mRNA in the present study. We observed that Notch1 shRNA inhibited cell proliferation together with decreased activity of the Notch1 pathway in vitro, and also markedly suppressed tumor formation of L02/HBx cells in a BALB/c nude mouse model in vivo. Furthermore, the blockade of Notch1 was capable of arresting the cell cycle in the G0/G1 phase through the downregulation of CyclinD1, CDK4, E2F1 and the upregulation of p21 and Rb, while all of these factors were involved in the CyclinD1/CDK4 pathway. Inhibition of Notch1 by shRNA markedly promoted the apoptosis of L02/HBx cells via the caspase-9-caspase-3 pathway. These data suggest that inhibition of Notch1 impairs the growth of human HBx-transformed L02 cells, and Notch1 may be a putative therapeutic target for human HBx-associated HCC.

View Figures

View References

1	El-Serag HB and Rudolph KL: Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
2	Engelke M, Mills K, Seitz S, et al: Characterization of a hepatitis B and hepatitis delta virus receptor binding site. Hepatology. 43:750–760. 2006. View Article : Google Scholar : PubMed/NCBI
3	Ye L, Dong N, Wang Q, et al: Progressive changes in hepatoma cells stably transfected with hepatitis B virus X gene. Intervirology. 51:50–58. 2008. View Article : Google Scholar : PubMed/NCBI
4	Artavanis-Tsakonas S: The molecular biology of the Notch locus and the fine tuning of differentiation in Drosophila. Trends Genet. 4:95–100. 1988. View Article : Google Scholar : PubMed/NCBI
5	Leong KG and Karsan A: Recent insights into the role of Notch signaling in tumorigenesis. Blood. 107:2223–2233. 2006. View Article : Google Scholar
6	Gridley T: Notch signaling and inherited disease syndromes. Hum Mol Genet. 12(Spec1): R9–R13. 2003. View Article : Google Scholar : PubMed/NCBI
7	Kopan R and Ilagan MX: The canonical Notch signaling pathway: unfolding the activation mechanism. Cell. 137:216–233. 2009. View Article : Google Scholar : PubMed/NCBI
8	Koch U and Radtke F: Notch signaling in solid tumors. Curr Top Dev Biol. 92:411–455. 2010. View Article : Google Scholar : PubMed/NCBI
9	Ellisen LW, Bird J, West DC, et al: TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell. 66:649–661. 1991.PubMed/NCBI
10	Allen TD, Rodriguez EM, Jones KD, et al: Activated Notch1 induces lung adenomas in mice and cooperates with Myc in the generation of lung adenocarcinoma. Cancer Res. 71:6010–6018. 2011. View Article : Google Scholar : PubMed/NCBI
11	Li J, Cui Y, Gao G, et al: Notch1 is an independent prognostic factor for patients with glioma. J Surg Oncol. 103:813–817. 2011. View Article : Google Scholar : PubMed/NCBI
12	Zhang Y, Li B, Ji ZZ, et al: Notch1 regulates the growth of human colon cancers. Cancer. 116:5207–5218. 2010. View Article : Google Scholar : PubMed/NCBI
13	Zardawi SJ, Zardawi I, McNeil CM, et al: High Notch1 protein expression is an early event in breast cancer development and is associated with the HER-2 molecular subtype. Histopathology. 56:286–296. 2010. View Article : Google Scholar : PubMed/NCBI
14	Bin Hafeez B, Adhami VM, Asim M, et al: Targeted knockdown of Notch1 inhibits invasion of human prostate cancer cells concomitant with inhibition of matrix metalloproteinase-9 and urokinase plasminogen activator. Clin Cancer Res. 15:452–459. 2009.
15	Sjolund J, Johansson M, Manna S, et al: Suppression of renal cell carcinoma growth by inhibition of Notch signaling in vitro and in vivo. J Clin Invest. 118:217–228. 2008. View Article : Google Scholar : PubMed/NCBI
16	Balint K, Xiao M, Pinnix CC, et al: Activation of Notch1 signaling is required for beta-catenin-mediated human primary melanoma progression. J Clin Invest. 115:3166–3176. 2005. View Article : Google Scholar : PubMed/NCBI
17	Yu XM, Phan T, Patel PN, et al: Chrysin activates Notch1 signaling and suppresses tumor growth of anaplastic thyroid carcinoma in vitro and in vivo. Cancer. 119:774–781. 2013. View Article : Google Scholar : PubMed/NCBI
18	Jonusiene V, Sasnauskiene A, Lachej N, et al: Down-regulated expression of Notch signaling molecules in human endometrial cancer. Med Oncol. 30:4382013. View Article : Google Scholar : PubMed/NCBI
19	Qi R, An H, Yu Y, et al: Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis. Cancer Res. 63:8323–8329. 2003.PubMed/NCBI
20	Viatour P, Ehmer U, Saddic LA, et al: Notch signaling inhibits hepatocellular carcinoma following inactivation of the RB pathway. J Exp Med. 208:1963–1976. 2011. View Article : Google Scholar : PubMed/NCBI
21	Giovannini C, Gramantieri L, Chieco P, et al: Selective ablation of Notch3 in HCC enhances doxorubicin’s death promoting effect by a p53-dependent mechanism. J Hepatol. 50:969–979. 2009.PubMed/NCBI
22	Wang F, Zhou H, Xia X, et al: Activated Notch signaling is required for hepatitis B virus X protein to promote proliferation and survival of human hepatic cells. Cancer Lett. 298:64–73. 2010. View Article : Google Scholar
23	Cheng B, Zheng Y, Guo X, et al: Hepatitis B viral X protein alters the biological features and expressions of DNA repair enzymes in LO2 cells. Liver Int. 30:319–326. 2010. View Article : Google Scholar : PubMed/NCBI
24	Luo J, Zhou H, Wang F, et al: The hepatitis B virus X protein downregulates NF-κB signaling pathways through decreasing the Notch signaling pathway in HBx-transformed L02 cells. Int J Oncol. 42:1636–1643. 2013.PubMed/NCBI
25	Wang F, Zhou H, Yang Y, et al: Hepatitis B virus X protein promotes the growth of hepatocellular carcinoma by modulation of the Notch signaling pathway. Oncol Rep. 27:1170–1176. 2012.PubMed/NCBI
26	Gao J, Dong Y, Zhang B, et al: Notch1 activation contributes to tumor cell growth and proliferation in human hepatocellular carcinoma HepG2 and SMMC7721 cells. Int J Oncol. 41:1773–1781. 2012.PubMed/NCBI
27	Lim SO, Park YM, Kim HS, et al: Notch1 differentially regulates oncogenesis by wildtype p53 overexpression and p53 mutation in grade III hepatocellular carcinoma. Hepatology. 53:1352–1362. 2011. View Article : Google Scholar : PubMed/NCBI
28	Zhou L, Wang DS, Li QJ, et al: The down-regulation of Notch1 inhibits the invasion and migration of hepatocellular carcinoma cells by inactivating the cyclooxygenase-2/Snail/E-cadherin pathway in vitro. Dig Dis Sci. 58:1016–1025. 2013. View Article : Google Scholar : PubMed/NCBI
29	Greenbaum LE: Cell cycle regulation and hepatocarcinogenesis. Cancer Biol Ther. 3:1200–1207. 2004. View Article : Google Scholar : PubMed/NCBI
30	Lu JW, Lin YM, Chang JG, et al: Clinical implications of deregulated CDK4 and Cyclin D1 expression in patients with human hepatocellular carcinoma. Med Oncol. 30:3792013. View Article : Google Scholar : PubMed/NCBI
31	Pok S, Wen V, Shackel N, et al: Cyclin E facilitates dysplastic hepatocytes to bypass G/S checkpoint in hepatocarcinogenesis. J Gastroenterol Hepatol. 28:1545–1554. 2013. View Article : Google Scholar : PubMed/NCBI
32	Tait SW and Green DR: Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol. 11:621–632. 2010. View Article : Google Scholar : PubMed/NCBI
33	Riedl SJ and Shi Y: Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol. 5:897–907. 2004. View Article : Google Scholar : PubMed/NCBI
34	Plati J, Bucur O and Khosravi-Far R: Apoptotic cell signaling in cancer progression and therapy. Integr Biol. 3:279–296. 2011. View Article : Google Scholar : PubMed/NCBI